Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.16T | 1.67T | 1.60T | 1.70T | 1.76T |
Gross Profit | 710.17B | 954.34B | 885.44B | 946.04B | 970.47B |
EBITDA | 387.69B | 698.75B | 515.41B | 603.29B | 651.43B |
Net Income | 278.81B | 490.60B | 432.77B | 477.69B | 480.38B |
Balance Sheet | |||||
Total Assets | 3.40T | 3.15T | 2.85T | 2.66T | 2.45T |
Cash, Cash Equivalents and Short-Term Investments | 2.06T | 2.25T | 1.88T | 1.71T | 1.74T |
Total Debt | 0.00 | 6.13B | 6.29B | 6.23B | 5.77B |
Total Liabilities | 673.07B | 546.40B | 587.82B | 593.08B | 572.30B |
Stockholders Equity | 2.72T | 2.60T | 2.27T | 2.07T | 1.87T |
Cash Flow | |||||
Free Cash Flow | -6.94B | 445.97B | 300.65B | 282.07B | 605.10B |
Operating Cash Flow | 12.07B | 462.10B | 322.84B | 289.66B | 612.11B |
Investing Cash Flow | 753.06B | -630.63B | 111.51B | 93.70B | -136.53B |
Financing Cash Flow | -195.13B | -236.96B | -290.97B | -337.01B | -194.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
85 Outperform | $84.92B | 19.55 | 23.93% | 1.98% | 1.26% | 6.84% | |
76 Outperform | $101.47B | 55.90 | 10.29% | 0.53% | -32.32% | -40.19% | |
73 Outperform | $84.45B | ― | -460.30% | ― | 30.24% | 27.61% | |
70 Outperform | $37.72B | 35.35 | 16.13% | 0.51% | -0.81% | -9.28% | |
69 Neutral | $10.42B | ― | -4.29% | ― | 21.11% | 87.93% | |
62 Neutral | $41.14B | -1.94 | -12.05% | 3.98% | 2.10% | -69.66% | |
57 Neutral | $41.02B | ― | -114.76% | ― | 5.31% | -15.57% |